Amgen Profile

200.88
USD 0.92  0.46%
50%
0%

Sale by Fritzky Edward V of 25000 shares of Amgen

Amgen insider trading alert for sale of common stock by Fritzky Edward V, the corporate stakeholder, on October 17, 2018. This event was filed by Amgen Inc with SEC on 2005-02-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Amgen Summary

Amgen (AMGN) is traded on BATS Exchange in USA. It is located in California U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 130.62 B. Amgen conducts business under Healthcare sector and is part of Biotechnology industry. This company has 647.27 M outstanding shares of which 10.24 M shares are presently shorted by private and institutional investors with about 3.87 trading days to cover. AMGEN currently holds about 29.39 B in cash with 8.55 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 45.41.
Check Amgen Probability Of Bankruptcy

Ownership Allocation (%)

Amgen Target Price Odds Analysis

Odds Below 200.88HorizonTargetOdds Above 200.88
22.70%30 days 200.88 76.89%
Based on normal probability distribution, the odds of Amgen to move above current price in 30 days from now is about 76.89% (This Amgen probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 30 days) .

Amgen Top Holders

Amgen Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Amgen Key Fundamentals

Amgen Against Markets

Amgen Current Ratings

Amgen 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
39 
Equity ratings for Amgen are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 20800 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Amgen SEC Filings
Amgen SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAmgen
ChairmanRobert BradwayView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 5 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
RegionNorth America
LocationCalifornia U.S.A
Business AddressOne Amgen Center Drive
Foreign Associates
ExchangeBATS Exchange
CIK Number0000318154
ISINUS0311621009
CUSIP031162100
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.amgen.com
Phone805 447 1000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestSeptember 28, 2018

Amgen Directors

Amgen Corporate Directors

Frank Herringer Independent Director
Francois Carbonnel Independent Director
Rebecca Henderson Independent Director
Check also Trending Equities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com